ZEB1 and breast carcinoma: Importantly, we demonstrated concomitantly high expression of Zeb1, LDHA, and MCT4 in breast cancer patients with an advanced TNM stage (Fig. 7E–G), highlighting that Zeb1-mediated dysregulation of aerobic glycolysis is functionally linked to breast tumor malignancy.